Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuya Nishiyama
Yuya Nishiyama
Takeda Pharmaceutical Company
Medicine
Internal medicine
Azilsartan
Blood pressure
Adverse effect
5
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Increasing effects of selective 5-HT2C receptor stimulation on evoked momentary urethral closure in female rats and humans.
2021
Journal of Pharmacology and Experimental Therapeutics
Izumi Kamo
Hiroshi Nagata
Gale OConnell
Takuya Kato
Akio Imanishi
Masako Kuno
Satoshi Okanishi
Kyoko Yoshikawa
Yuya Nishiyama
Show All
Source
Cite
Save
Citations (0)
Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
2021
Clinical and Experimental Nephrology
Shuichi Ito
Yuya Nishiyama
Kenkichi Sugiura
Kazuaki Enya
Show All
Source
Cite
Save
Citations (0)
A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension
2018
Blood Pressure
Hiromi Rakugi
Kohei Shimizu
Yuya Nishiyama
Yuhei Sano
Yuusuke Umeda
Show All
Source
Cite
Save
Citations (3)
Effects of triple combination therapy with azilsartan/amlodipine/hydrochlorothiazide on office/home blood pressure: a randomized-controlled trial in Japanese essential hypertensive patients
2017
Blood Pressure Monitoring
Hiromi Rakugi
Kohei Shimizu
Yuhei Sano
Yuya Nishiyama
Yoshinobu Kinugawa
Souhei Terashio
Show All
Source
Cite
Save
Citations (2)
Randomized, double‐blind, phase III study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes
2017
Diabetes, Obesity and Metabolism
Kohei Kaku
Shuuji Sumino
Masafumi Katou
Yuya Nishiyama
Yoshinobu Kinugawa
Show All
Source
Cite
Save
Citations (8)
1